COVID-19: Two cardiac biomarkers ‘flag risk’
Elevated levels are associated with a threefold risk of death, cardiologists find
Measurement of two cardiac biomarkers within 24 hours of admission to hospital with COVID-19 might help with risk stratification, Italian specialists say.
Their study shows that patients admitted with elevated levels of both high-sensitivity cardiac troponin I (hs-TnI) and B-type natriuretic peptide (BNP) had three times the risk of death from any cause over a median follow-up of 12 days.
